Jonathan I. Lieber

Chief Financial Officer, Altus Pharmaceuticals Inc.

Companies

RallybioChief financial officer Feb 16, 2024 to now¹
Decoy Therapeutics Inc.Board member Jun 22, 2020 to now²
RallybioOfficer Feb 1, 2023 to Mar 16, 2023³
Applied Genetic Technologies CorporationChief financial officer Sep 21, 2021 to Dec 1, 2022⁴
Checkmate PharmaceuticalsOfficer Aug 6, 2020 to Aug 6, 2020⁵
OcugenChief financial officer Jun 22, 2015 to Oct 3, 2018⁶
RepligenChief financial officer Sep 24, 2012 to Mar 12, 2013⁷

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Rallybio RLYB4,115 shares⁸$67.2K at $16.33Feb 23, 2026
Decoy Therapeutics Inc. DCOY2,002 shares⁹$2.4K at $1.18Aug 31, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Aug 31, 2026Granted 2,000 shares of Decoy Therapeutics Inc.⁹
Feb 23, 2026Sold 789 shares at $5.06 of Rallybio⁸
Feb 18, 2026Granted 2,500 shares of Rallybio⁸
Mar 14, 2023Bought 5,000 shares at $5.21 of Rallybio¹⁰
Jan 3, 2023Granted 1,440 shares of Decoy Therapeutics Inc.¹¹
Jun 7, 2022Bought 37,500 shares at $0.19 of Decoy Therapeutics Inc.¹²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARRallybio, Chief financial officer
2
SEC EDGARDecoy Therapeutics Inc., Board member
3
SEC EDGARRallybio, Officer
4
SEC EDGARApplied Genetic Technologies Corporation, Chief financial officer
5
SEC EDGARCheckmate Pharmaceuticals, Officer
6
SEC EDGAROcugen, Chief financial officer
7
SEC EDGARRepligen, Chief financial officer
8
SEC EDGARRallybio shares after the filing of Feb 23, 2026
9
SEC EDGARDecoy Therapeutics Inc. shares after the filing of Aug 31, 2026
10
SEC EDGARForm 4 filed Mar 16, 2023
11
SEC EDGARForm 4 filed Jan 5, 2023
12
SEC EDGARForm 4 filed Jun 8, 2022